1887

Abstract

Decreased ciprofloxacin susceptibility (DCS) and multidrug resistance in typhoidal Salmonella isolates in areas of endemicity are significant therapeutic problems. Guidelines for azithromycin disc diffusion and MIC interpretive criteria for Salmonella enterica serovar Typhi were published recently by the Clinical and Laboratory Standards Institute in 2015. We investigated the antimicrobial susceptibility pattern of azithromycin in 100 isolates of Salmonella Typhi (n=80), Paratyphi A (n=18) and B (n=2) recovered from bloodstream infections from January 2013 to December 2015. Zone sizes were extrapolated against MIC values, and a scatter plot was constructed. The azithromycin MICs by Etest ranged from 2 to 16 µg ml, while the disc diffusion diameters were from 13 to 22 mm. We observed that the margin of the zone of inhibition around the azithromycin disc may not be very clear and therefore difficult to interpret and that there was wide variation in the zone sizes for the same MIC value in both serovars. DCS was observed in 85 % of Salmonella Typhi recovered (68/80) and in 15/18 (83.3 %) Paratyphi A isolates. Judicious use of azithromycin is advocated as an alternative oral agent in endemic areas where DCS is common.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000390
2016-12-16
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/12/1536.html?itemId=/content/journal/jmm/10.1099/jmm.0.000390&mimeType=html&fmt=ahah

References

  1. Chau T. T., Campbell J. I., Galindo C. M., Hoang N. V. M., Diep T. S., Nga T. T., Chau N. N. V., Tuan P. Q., Page A. L. et al.( 2007;). Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. . Antimicrob Agents Chemother51:4315–4323. [CrossRef][PubMed]
    [Google Scholar]
  2. CLSI( 2015;). Performance Standards for Antimicrobial Susceptibility Testing; 24th Informational Supplement. . M100–S24. Wayne, PA:: Clinical and Laboratory Standards Institute;.
  3. Crump J. A., Sjölund-Karlsson M., Gordon M. A., Parry C. M..( 2015;). Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections. . Clin Microbiol Rev28:901–937. [CrossRef][PubMed]
    [Google Scholar]
  4. Dutta S., Das S., Mitra U., Jain P., Roy I., Ganguly S. S., Ray U., Dutta P., Paul D. K..( 2014;). Antimicrobial resistance, virulence profiles and molecular subtypes of Salmonella enterica serovars Typhi and Paratyphi A blood isolates from Kolkata, India during 2009–2013. . PLoS One9:e101347. [CrossRef]
    [Google Scholar]
  5. Frenck R. W., Nakhla I. A., Sultan Y., Bassily S. B., Girgis F. Y., David J., Butler T. C., Girgis N. I., Morsy M..( 2000;). Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. . Clin Infect Dis31:1134–1138. [CrossRef][PubMed]
    [Google Scholar]
  6. Frenck R. W., Mansour A., Nakhla I., Sultan Y., Putnam S., Wierzba T., Morsy M., Knirsch C..( 2004;). Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. . Clin Infect Dis38:951–957. [CrossRef][PubMed]
    [Google Scholar]
  7. Hassing R. J., Goessens W. H., van Pelt W., Mevius D. J., Stricker B. H., Molhoek N., Verbon A., van Genderen P. J..( 2014;). Salmonella subtypes with increased MICs for azithromycin in travelers returned to The Netherlands. . Emerg Infect Dis20:705–708. [CrossRef][PubMed]
    [Google Scholar]
  8. Kariuki S., Revathi G., Kiiru J., Mengo D. M., Mwituria J., Muyodi J., Munyalo A., Teo Y. Y., Holt K. E. et al.( 2010;). Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in southeast Asia. . J Clin Microbiol48:2171–2176. [CrossRef][PubMed]
    [Google Scholar]
  9. Misra R., Prasad K. N., Amrin N., Kapoor P., Singh S., Ghar M..( 2015;). Absence of multidrug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolates with intermediate susceptibility to ciprofloxacin. . Trans R Soc Trop Med Hyg109:538–540. [CrossRef]
    [Google Scholar]
  10. Molloy A., Nair S., Cooke F. J., Wain J., Farrington M., Lehner P. J., Torok M. E..( 2010;). First report of Salmonella enterica serotype Paratyphi A azithromycin resistance leading to treatment failure. . J Clin Microbiol48:4655–4657. [CrossRef][PubMed]
    [Google Scholar]
  11. Nguyen M. C. P., Woerther P.-L., Bouvet M., Andremont A., Leclercq R., Canu A..( 2009;). Escherichia coli as reservoir for macrolide resistance genes. . Emerg Infect Dis15:1648–1650. [CrossRef]
    [Google Scholar]
  12. Ochiai R. L., Acosta C. J., Danovaro-Holliday M. C., Baiqing D., Bhattacharya S. K., Agtini M. D., Bhutta Z. A., Canh D. G., Ali M. et al.( 2008;). A study of typhoid fever in five Asian countries: disease burden and implications for controls. . Bull World Health Organ86:260–268. [CrossRef][PubMed]
    [Google Scholar]
  13. Parry C. M., Basnyat B., Crump J. A..( 2013;). The management of antimicrobial-resistant enteric fever. . Expert Rev Anti Infect Ther11:1259–1261. [CrossRef][PubMed]
    [Google Scholar]
  14. Parry C. M., Thieu N. T., Dolecek C., Karkey A., Gupta R., Turner P., Dance D., Maude R. R., Ha V. et al.( 2015;). Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A. . Antimicrob Agents Chemother59:2756–2764. [CrossRef][PubMed]
    [Google Scholar]
  15. Sjölund-Karlsson M., Joyce K., Blickenstaff K., Ball T., Haro J., Medalla F. M., Fedorka-Cray P., Zhao S., Crump J. A., Whichard J. M..( 2011;). Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates from the United States. . Antimicrob Agents Chemother55:3985–3989. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000390
Loading
/content/journal/jmm/10.1099/jmm.0.000390
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error